Mark A. Klausner
Impact in
- Nephrology top 1%
- Parathyroid Disorders and Treatments
- Hematology top 5%
- Erythropoietin and Anemia Treatment
Papers in
-
- Parathyroid Disorders and Treatments 7
-
- Erythropoietin and Anemia Treatment 5
- Chronic Myeloid Leukemia Treatments 2
- Co-authors
- Karl Insogna (7 shared papers)Munro Peacock (7 shared papers)Mary D. Ruppe (7 shared papers)Jeffrey S. Humphrey (7 shared papers)Thomas J. Weber (7 shared papers)Erik A. Imel (7 shared papers)Thomas O. Carpenter (5 shared papers)Xiaoping Zhang (5 shared papers)
- Journals
- The Journal of Clinical Pharmacology (5 papers)Blood (2 papers)Journal of Pharmaceutical Sciences (2 papers)Pharmacoepidemiology and Drug Safety (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)
- Partner nations
- United StatesCanadaSingapore
In The Last Decade
Mark A. Klausner
24 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 91
- Nephrology 423
- Hematology 277
- Biochemistry 128
- Critical Care and Intensive Care Medicine 49
- Genetics 85
Countries citing papers authored by Mark A. Klausner
This map shows the geographic impact of Mark A. Klausner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Klausner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Klausner more than expected).
Fields of papers citing papers by Mark A. Klausner
This network shows the impact of papers produced by Mark A. Klausner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Klausner. The network helps show where Mark A. Klausner may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Klausner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 363 | |
| 2 | 2014 | 219 | |
| 3 | 2015 | 119 | |
| 4 | 1997 | 96 | |
| 5 | 2005 | 90 | |
| 6 | 2001 | 49 | |
| 7 | 2016 | 47 | |
| 8 | 2015 | 43 | |
| 9 | 1999 | 40 | |
| 10 | 1998 | 35 | |
| 11 | 1998 | 33 | |
| 12 | 2005 | 27 | |
| 13 | 1999 | 27 | |
| 14 | 1997 | 22 | |
| 15 | 1997 | 9 | |
| 16 | 2004 | 4 | |
| 17 | 1988 | 3 | |
| 18 | 2014 | 3 | |
| 19 | 1988 | 2 | |
| 20 | 2004 | 2 |
About Mark A. Klausner
Mark A. Klausner is a scholar working on Nephrology, Hematology, Infectious Diseases, Oncology and Pharmacology, having authored 24 papers that have together received 1.2k indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (7 papers), Erythropoietin and Anemia Treatment (5 papers), Antifungal resistance and susceptibility (3 papers), Bipolar Disorder and Treatment (2 papers), Treatment of Major Depression (2 papers), Advancements in Transdermal Drug Delivery (2 papers), Anesthesia and Sedative Agents (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Nephrology (423 citations), Hematology (277 citations), Biochemistry (128 citations), Critical Care and Intensive Care Medicine (49 citations) and Genetics (85 citations). Mark A. Klausner has collaborated with scholars based in United States, Canada and Singapore. Frequent co-authors include Karl Insogna, Munro Peacock, Mary D. Ruppe, Jeffrey S. Humphrey, Thomas J. Weber, Erik A. Imel, Thomas O. Carpenter, Xiaoping Zhang, Addison K. May and Peter Bowers. Their work appears in journals such as The Journal of Clinical Pharmacology, Blood, Journal of Pharmaceutical Sciences, Pharmacoepidemiology and Drug Safety and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.